Search Results - "Vasku, Vladimir"

Refine Results
  1. 1

    Polymorphisms in some proinflammatory genes (TNFα and β, IL‐1β, IL‐6, ADAM17) in severe chronic venous disease by Slonková, Veronika, Vašků, Anna, Vašků, Vladimír

    “…Background Chronic venous disease (CVD) is a common disorder of lower extremities. Objectives The study was scheduled to investigate the relationship between…”
    Get full text
    Journal Article
  2. 2
  3. 3

    New Genetic Markers of Skin T-Cell Lymphoma Treatment by Vašků, Vladimír, Fialová, Petra, Vašků, Anna

    Published in Genes (13-03-2024)
    “…Cutaneous T-cell lymphomas (CTCL) can be described as chronic skin inflammation lesions with the content of malignant T cells and they are considered to be…”
    Get full text
    Journal Article
  4. 4

    MiR-21 binding site SNP within ITGAM associated with psoriasis susceptibility in women by Hruska, Pavel, Kuruczova, Daniela, Vasku, Vladimir, Bienertova-Vasku, Julie

    Published in PloS one (18-06-2019)
    “…Great progress has been made in the understanding of inflammatory processes in psoriasis. However, clarifying the role of genetic variability in processes…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Some New Aspects of Genetic Variability in Patients with Cutaneous T-Cell Lymphoma by Vašků, Vladimír, Máchal, Jan, Zlámal, Filip, Vašků, Anna

    Published in Genes (18-12-2022)
    “…Cutaneous T-cell lymphoma (CTCL) is a group of T-cell malignancies that develop in the skin. Though studied intensively, the etiology and pathogenesis of CTCL…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Paraneoplastic Scleroderma: Are There Any Clues? by Jedlickova, Hana, Durčanská, Veronika, Vašků, Vladimír

    Published in Acta dermatovenerologica Croatica (01-04-2016)
    “…Dear Editor, Scleroderma associated with neoplasia is rare, with only a small number of cases reported. We describe 4 patients with paraneoplastic scleroderma…”
    Get more information
    Journal Article
  9. 9

    Lack of omalizumab efficacy in severe atopic dermatitis with extremely elevated IgE levels: two case reports and a literature review by Necas, Miroslav, Vasku, Vladimir, Brezinova, Eva

    “…The authors present two cases of severe atopic dermatitis with extremely elevated IgE levels treated with omalizumab. The effect of this treatment was…”
    Get full text
    Journal Article
  10. 10

    Measurement of transepidermal water loss in localized scleroderma by Ďurčanská, Veronika, Jedličková, Hana, Vašků, Vladimír

    Published in Dermatologic therapy (01-05-2016)
    “…ABSTRACT Localized scleroderma (LS) is a disease characterized by fibrotic changes in the dermis. Connective tissue growth factor and transforming growth…”
    Get full text
    Journal Article
  11. 11

    Paraneoplastic vasculitis and paraneoplastic vascular syndromes by Buggiani, Gionata, Krysenka, Alena, Grazzini, Marta, Vašků, Vladimír, Hercogová, Jana, Lotti, Torello

    Published in Dermatologic therapy (01-11-2010)
    “…ABSTRACT Paraneoplastic syndromes are localized or diffuse pathologic manifestations that may occur in subjects affected by neoplastic diseases, even occult…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Three retinoid X receptor gene polymorphisms in plaque psoriasis and psoriasis guttata by Vasků, Vladimír, Bienertová Vasků, Julie, Pávková Goldbergová, Monika, Vasků, Anna

    Published in Dermatology (Basel) (01-01-2007)
    “…Polymorphisms in retinoid X receptors (RXRs) are very interesting from the point of view of a possible association of their variability with psoriasis. A total…”
    Get more information
    Journal Article
  15. 15

    Matrix metalloproteinase-2 promoter variability in psoriasis by Vasku, Vladimir, Bienertova Vasku, Julie, Slonková, Veronika, Kaňková, Kateřina, Vasku, Anna

    Published in Archives of Dermatological Research (01-07-2009)
    “…The expression of matrix metalloproteinase-2 was observed to be significantly upregulated in psoriasis. The aim of this study was to associate the DNA…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19

    Polymorphisms in inflammation genes (angiotensinogen, TAP1 and TNF-β) in psoriasis by VASKU, Vladimir, VASKU, Anna, HOLLA, Lydie Izakovicova, TSCHÖPLOVA, Svatava, KANKOVA, Katerina, BENAKOVA, Nina, SEMRADOVA, Vera

    Published in Archives of Dermatological Research (01-11-2000)
    “…This study focused on the association between plaque psoriasis and polymorphisms of several inflammation genes. Included in the study were 142 Caucasian…”
    Get full text
    Journal Article
  20. 20

    Risankizumab for the Treatment of Moderate-to-Severe Psoriasis: Real-Life Multicenter Experience from the Czech Republic by Gkalpakiotis, Spyridon, Cetkovska, Petra, Arenberger, Petr, Dolezal, Tomas, Arenbergerova, Monika, Velackova, Barbora, Fialova, Jorga, Kojanova, Martina

    Published in Dermatology and therapy (01-08-2021)
    “…Introduction Risankizumab has been approved for the treatment of moderate-to-severe plaque psoriasis; however, real-life data are limited. Our objectives were…”
    Get full text
    Journal Article